Biolase Stock Investor Sentiment

BIOL Stock  USD 0.14  0.01  6.67%   
About 56% of BIOLASE's investor base is looking to short. The analysis of overall sentiment of trading BIOLASE stock suggests that many investors are alarmed at this time. BIOLASE's investor sentiment overview provides quick insight into current market opportunities from investing in BIOLASE. The current market sentiment, together with BIOLASE's historical and current headlines, can help investors time the market. In addition, many technical investors use BIOLASE stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
BIOLASE stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BIOLASE daily returns and investor perception about the current price of BIOLASE as well as its diversification or hedging effects on your existing portfolios.
  

BIOLASE Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards BIOLASE can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at news.google.com         
StockNews.com Initiates Coverage on BIOLASE - Defense World
Google News at Macroaxis
over a week ago at news.google.com         
BIOLASE Coverage Initiated by Analysts at StockNews.com - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
BIOLASE Receives New Coverage from Analysts at StockNews.com - Defense World
Google News at Macroaxis
over three weeks ago at news.google.com         
BIOLASE Now Covered by StockNews.com - Defense World
Google News at Macroaxis
over a month ago at insidermonkey.com         
BIOLASE, Inc. Q4 2023 Earnings Call Transcript
insidermonkey News
over a month ago at insidermonkey.com         
Acquisition by Garrett Sato of 110888 shares of BIOLASE at 0.84 subject to Rule 16b-3
insidermonkey News
over a month ago at finance.yahoo.com         
BIOLASE, Inc. Q4 2023 Earnings Call Transcript
Yahoo News
over a month ago at insidermonkey.com         
BIOLASE, Inc. Q4 2023 Earnings Call Transcript
insidermonkey News
over a month ago at finance.yahoo.com         
BIOLASE, Inc. Q4 2023 Earnings Call Transcript
Yahoo News
over a month ago at investorplace.com         
BIOL Stock Earnings Biolase Beats EPS, Misses Revenue for Q4 2023
sbwire news
over a month ago at investing.com         
Earnings call BIOLASE reports modest revenue gain and optimistic 2024 outlook
Investing News at Macroaxis
over a month ago at seekingalpha.com         
Biolase GAAP EPS of -1.76 beats by 0.80, revenue of 13.49M beats by 0.27M
seekingalpha News
over a month ago at accesswire.com         
Biolase Reports Full-Year 2023 Results Expects Continued Revenue Growth In 2024
news
over a month ago at finance.yahoo.com         
Biolase Reports Full-Year 2023 Results Expects Continued Revenue Growth In 2024
Yahoo News
over a month ago at news.google.com         
BIOLASE Scheduled to Post Earnings on Thursday - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about BIOLASE that are available to investors today. That information is available publicly through BIOLASE media outlets and privately through word of mouth or via BIOLASE internal channels. However, regardless of the origin, that massive amount of BIOLASE data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BIOLASE news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BIOLASE relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BIOLASE's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BIOLASE alpha.

BIOLASE Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Biolase Announces Common Stock Shares Update - TipRanks.com - TipRanks
02/21/2024
2
BIOLASE, Inc. Short Interest Up 602.5 percent in February
02/29/2024
3
BIOLASE Coverage Initiated by Analysts at StockNews.com - Defense World
03/08/2024
4
Disposition of 1395 shares by Jonathan Lord of BIOLASE subject to Rule 16b-3
03/15/2024
5
Biolase Reports Full-Year 2023 Results Expects Continued Revenue Growth In 2024
03/21/2024
6
Earnings call BIOLASE reports modest revenue gain and optimistic 2024 outlook
03/22/2024
7
BIOLASE Now Covered by StockNews.com - Defense World
03/25/2024
8
StockNews.com Initiates Coverage on BIOLASE - Defense World
04/17/2024
When determining whether BIOLASE is a strong investment it is important to analyze BIOLASE's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BIOLASE's future performance. For an informed investment choice regarding BIOLASE Stock, refer to the following important reports:
Check out BIOLASE Hype Analysis, BIOLASE Correlation and BIOLASE Performance.
For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for BIOLASE Stock analysis

When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(29.44)
Revenue Per Share
38.469
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.29)
Return On Equity
(6.03)
The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.